Other Species / Isoforms
  DHX57 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K13
RRKGKPGKGGGKGSS
0 1
DHX57 (human) RRKGKPGKGGGKGSS K13
DHX57 (mouse) RRKGKPGkGDGKGSS K13-ac
S28-p
RGGRGGRsHAsKSHG
0 1
DHX57 (human) RGGRGGRsHAsKSHG S28-p
DHX57 (mouse) RGGRGGKGHMNkSHG G28
S31-p
RGGRsHAsKSHGSGG
0 1
DHX57 (human) RGGRsHAsKSHGSGG S31-p
DHX57 (mouse) RGGKGHMNkSHGGGG N31
K32
GGRsHAsKSHGSGGG
0 1
DHX57 (human) GGRsHAsKSHGSGGG K32
DHX57 (mouse) GGKGHMNkSHGGGGG K32-ub
R51-m1
GGGGGGNrKASSRIW
0 1
DHX57 (human) GGGGGGNrKASSRIW R51-m1
DHX57 (mouse) GGGGGGSRKASNRIW R52
S74-p
FSESRRPsRPsNSNI
0 8
DHX57 (human) FSESRRPsRPsNSNI S74-p
DHX57 (mouse) FTEPKRPSRPCDSNK S75
S77-p
SRRPsRPsNSNISKG
0 1
DHX57 (human) SRRPsRPsNSNISKG S77-p
DHX57 (mouse) PKRPSRPCDSNKSKG C78
S127-p
EQDADAGsERGLsGE
Upstream
0 30
Treatment
  • dasatinib
  • ischemia
DHX57 (human) EQDADAGsERGLsGE S127-p
DHX57 (mouse) EQGADAGsERGTSGE S128-p
S132-p
AGsERGLsGEEEDDE
Upstream
0 17
Treatment
  • lapatinib
DHX57 (human) AGsERGLsGEEEDDE S132-p
DHX57 (mouse) AGsERGTSGEEEDSE S133
S301
TKNVQENSLEICKFY
0 1
DHX57 (human) TKNVQENSLEICKFY S301
DHX57 (mouse) SKNVRDTsPEtCKFY S301-p
I304
VQENSLEICKFYLKG
0 1
DHX57 (human) VQENSLEICKFYLKG I304
DHX57 (mouse) VRDTsPEtCKFYLKG T304-p
T377-p
PLVAFYStNENLPLA
0 1
DHX57 (human) PLVAFYStNENLPLA T377-p
DHX57 (mouse) PLVAFYSTNENLPLA T377
K396-ub
ISEFLYDkALTFAET
0 4
DHX57 (human) ISEFLYDkALTFAET K396-ub
DHX57 (mouse) ISEFLYGkALEFAKT K396-ub
S444-p
VNFLPVPsRTRINNP
0 2
DHX57 (human) VNFLPVPsRTRINNP S444-p
DHX57 (mouse) VNVPPVPSETRISKP S444
S465-p
IPNNSFVsNQIPEVE
0 1
DHX57 (human) IPNNSFVsNQIPEVE S465-p
DHX57 (mouse) VPSNTFLSNQMLEGE S465
S475-p
IPEVEKAsEsEEsDE
0 2
DHX57 (human) IPEVEKAsEsEEsDE S475-p
DHX57 (mouse) MLEGERLSELEEDAD S475
S477-p
EVEKAsEsEEsDEDD
0 3
DHX57 (human) EVEKAsEsEEsDEDD S477-p
DHX57 (mouse) EGERLSELEEDADED L477
S480-p
KAsEsEEsDEDDGPA
0 4
DHX57 (human) KAsEsEEsDEDDGPA S480-p
DHX57 (mouse) LSELEEDADEDEGPA A481
K512-m1
KRYDWQAkSVHAENG
0 1
DHX57 (human) KRYDWQAkSVHAENG K512-m1
DHX57 (mouse) KRYDRPAKSLFAENS K513
T639-p
ESVKSSAtRLLYCTT
0 1
DHX57 (human) ESVKSSAtRLLYCTT T639-p
DHX57 (mouse) ESVKSSATRLLYCTT T640
S677
VHERTEESDFLLLVL
0 1
DHX57 (human) VHERTEESDFLLLVL S677
DHX57 (mouse) VHERTEEsDFLLLVL S678-p
Y741-p
DAIAVTRyVLQDGSP
0 2
DHX57 (human) DAIAVTRyVLQDGSP Y741-p
DHX57 (mouse) DALAVTRyVLQDGSP Y742-p
Y749-p
VLQDGSPyMRsMKQI
Upstream
0 1
Treatment
  • nocodazole
DHX57 (human) VLQDGSPyMRsMKQI Y749-p
DHX57 (mouse) VLQDGSPYMRSMKQI Y750
S752-p
DGSPyMRsMKQISKE
Upstream
0 1
Treatment
  • nocodazole
DHX57 (human) DGSPyMRsMKQISKE S752-p
DHX57 (mouse) DGSPYMRSMKQIAKE S753
S1142-p
TKEGVRAsYNYCRQN
0 1
DHX57 (human) TKEGVRAsYNYCRQN S1142-p
DHX57 (mouse) TKESARASYNYCRQN S1144
K1237
SPEGKFQKTSTGAVR
0 1
DHX57 (human) SPEGKFQKTSTGAVR K1237
DHX57 (mouse) TPEGKFQkTSSGVVR K1239-ub
T1256
SAELKFVTKNDGyVH
0 1
DHX57 (human) SAELKFVTKNDGyVH T1256
DHX57 (mouse) SAELKFVtKNDGyVH T1258-p
Y1261-p
FVTKNDGyVHIHPsS
0 8
DHX57 (human) FVTKNDGyVHIHPsS Y1261-p
DHX57 (mouse) FVtKNDGyVHIHPSS Y1263-p
S1267-p
GyVHIHPsSVNyQVR
0 1
DHX57 (human) GyVHIHPsSVNyQVR S1267-p
DHX57 (mouse) GyVHIHPSSVNYQVR S1269
Y1271-p
IHPsSVNyQVRHFDS
0 1
DHX57 (human) IHPsSVNyQVRHFDS Y1271-p
DHX57 (mouse) IHPSSVNYQVRHFDS Y1273
S1377
PRGSRIISTIVKLVT
0 1
DHX57 (human) PRGSRIISTIVKLVT S1377
DHX57 (mouse) PRGSRIIsMIVKLIT S1379-p